Korea FilingsFull brief — $39

NeopharmCO.,LTD.

(주)네오팜 · KOSDAQ: 092730 · Manufacture of cosmetics

Key facts

Korean name
(주)네오팜
Market / ticker
KOSDAQ · 092730
Industry
Manufacture of cosmetics
Established
2000-07-01
Fiscal year ends
December
Website
neopharm.co.kr
DART corp code
00551920
Latest revenue
₩132.2B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩97.1B₩119.0B₩132.2B
Operating income₩25.3B₩24.7B₩28.8B
Net income₩23.2B₩23.1B₩27.8B
Total assets₩177.5B₩192.4B₩217.8B
Total liabilities₩17.4B₩15.6B₩22.5B
Total equity₩160.0B₩176.9B₩195.4B
Share capital₩4.1B₩8.0B₩8.0B

Consolidated statements · FY2025 operating margin 21.8% · liabilities to equity 11% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 26 (current)대주회계법인Unqualified
Term 25 (prior)대주회계법인Unqualified
Term 24 (two years prior)삼덕회계법인Unqualified

Largest shareholder history

DateLargest shareholder (Korean)StakeCause (Korean)
2023년 03월 23일(주)잇츠한불외 2명임원사임
2024년 06월 03일(주)잇츠한불외 4명지분매입(장내)
2024년 10월 31일(주)잇츠한불외 4명무상증자
2024년 11월 25일(주)잇츠한불외 4명지분매입(장내)
2024년 12월 02일(주)잇츠한불외 4명지분매입(장내)
2025년 03월 26일(주)잇츠한불외 3명임원사임
2025년 10월 22일(주)잇츠한불외 3명지분매입(장내)

Recent filings

DateFilingOriginal
2026-08-24Investor relations eventDART
2026-08-14Half-year report (2026.06)DART
2026-08-07Preliminary operating results (fair disclosure)DART
2026-06-08Large shareholding (5%+) reportDART
2026-05-14Quarterly report (2026.03)DART
2026-05-08Investor relations eventDART
2026-05-08Preliminary operating results (fair disclosure)DART
2026-05-06Large shareholding (5%+) reportDART
2026-05-06Officer / major shareholder ownership reportDART
2026-04-28Large shareholding (5%+) reportDART
2026-04-01Large shareholding (5%+) reportDART
2026-03-25Corporate value-up plan (voluntary)DART
2026-03-24Independent director appointment / dismissal / resignationDART
2026-03-24Annual general meeting resultsDART
2026-03-16Annual report (2025.12)DART
2026-03-16Audit report submittedDART
2026-03-09Proxy solicitation reference documentDART
2026-03-09Notice of shareholders meetingDART
2026-03-05Large shareholding (5%+) reportDART
2026-03-03Investor relations eventDART

Showing the 20 most recent of 31 filings. The full brief lists all of them.

Full brief on NeopharmCO.,LTD. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Manufacture of cosmetics

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.